RE:Biomarker approvalPMN is in the late stages of developing its own biomarkers for AD ... They have identified at least 8 of their own targets (regents) that they are looking to be able to have a blood assey for. One of course will be to suit the PMN310, the others will be used to provide data to other researchers based on their specifications. I honestly can say I dont know if any of them are for Tau. A lot of this is in the hands of our JV partner and the only thing you might get out of them is their postal code.